Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

Dimosthenis Skarlos, E. Samantas, Evangelos Briassoulis, +12

Annals of Oncology

Radiation MedicineHealth SciencesRadiation TherapyMedicineEarly Versus +8

Evaluation of six tumor markers in patients with carcinoma of unknown primary

Nicholas Pavlidis, J. Kalef‐Ezra, Evangelos Briassoulis, +8

Medical and Pediatric Oncology

Cancer PathologyUnknown PrimaryPathologyCancer RegistrationTumor Biology +17

Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology Group

Dimitrios Bafaloukos, Dimosthenis Tsoutsos, Haralabos P. Kalofonos, +11

Annals of Oncology

MedicineMelanomaVersus TemozolomideDermatologyCancer Treatment +4

Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.

P. Kosmidis, D. Skarlos, D. Theocharis, +4

Journal of Clinical Oncology

Biomarkers of head and neck cancer, tools or a gordian knot?

Evangeli Lampri, Georgios Chondrogiannis, E. Ioachim, +6

PubMed

Neck CancerGordian KnotPathologyDermatologyTumor Biology +18

Dose-Dense Sequential Chemotherapy With Epirubicin and Paclitaxel Versus the Combination, as First-Line Chemotherapy, in Advanced Breast Cancer: A Randomized Study Conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, Christos Papadimitriou, Urania Dafni, +13

Journal of Clinical Oncology

Temozolomide in Combination With Docetaxel in Patients With Advanced Melanoma: A Phase II Study of the Hellenic Cooperative Oncology Group

D. Bafaloukos, Helen Gogas, V. Georgoulias, +7

Journal of Clinical Oncology

Phase Ii StudyPharmacotherapyMetronomic ChemotherapyDermatologyNeuro-oncology +14

Is interferon-a an active agent in Castleman’s disease?

Nicholas Pavlidis, Evangelos Briassoulis, G. Klouvas, +1

Annals of Oncology

Disease MechanismPathogenesisImmunologyImmune SystemMedicine +2

Fluorouracil and Leucovorin with or without Interferon Alfa-2a as Adjuvant Treatment, in Patients with High-Risk Colon Cancer

George Fountzilas, A. Zisiadis, Urania Dafni, +15

Oncology

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

Maike Ihnen, Ralph M. Wirtz, Konstantine T. Kalogeras, +11

British Journal of Cancer